Suven Life Sciences Limited (SUVEN) - Cash Flow Conversion Efficiency

Latest as of September 2025: -0.368x

Based on the latest financial reports, Suven Life Sciences Limited (SUVEN) has a cash flow conversion efficiency ratio of -0.368x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Rs-1.03 Billion ≈ $-11.18 Million USD) by net assets (Rs2.81 Billion ≈ $30.42 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See SUVEN net asset quality score to measure how much of total assets are equity-financed.

Suven Life Sciences Limited - Cash Flow Conversion Efficiency Trend (2005–2025)

This chart illustrates how Suven Life Sciences Limited's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check Suven Life Sciences Limited cash earnings quality to evaluate the quality of earnings relative to operating cash generation.

Suven Life Sciences Limited Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Suven Life Sciences Limited ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
Green Cross Corp
KO:006280
0.094x
Sun Country Airlines Holdings Inc
NASDAQ:SNCY
0.045x
Tanla Platforms Limited
NSE:TANLA
0.074x
RHÖN-KLINIKUM Aktiengesellschaft
XETRA:RHK
-0.019x
Flotek Industries Inc
NYSE:FTK
0.000x
Cera Sanitaryware Limited
NSE:CERA
0.052x
Zhejiang Xinhua Chemical Co Ltd
SHG:603867
0.034x
CH. Karnchang Public Company Limited
BK:CK-R
0.104x

Annual Cash Flow Conversion Efficiency for Suven Life Sciences Limited (2005–2025)

The table below shows the annual cash flow conversion efficiency of Suven Life Sciences Limited from 2005 to 2025. For the full company profile with market capitalisation and key ratios, see SUVEN company net worth.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-03-31 Rs1.10 Billion
≈ $11.89 Million
Rs-1.48 Billion
≈ $-16.06 Million
-1.350x -215.69%
2024-03-31 Rs2.70 Billion
≈ $29.20 Million
Rs-1.15 Billion
≈ $-12.49 Million
-0.428x -55.59%
2023-03-31 Rs3.75 Billion
≈ $40.59 Million
Rs-1.03 Billion
≈ $-11.16 Million
-0.275x +79.28%
2022-03-31 Rs961.45 Million
≈ $10.40 Million
Rs-1.28 Billion
≈ $-13.79 Million
-1.327x -49.20%
2021-03-31 Rs1.08 Billion
≈ $11.68 Million
Rs-960.24 Million
≈ $-10.38 Million
-0.889x +34.25%
2020-03-31 Rs1.43 Billion
≈ $15.50 Million
Rs-1.94 Billion
≈ $-20.96 Million
-1.352x -3261.03%
2019-03-31 Rs8.31 Billion
≈ $89.87 Million
Rs355.49 Million
≈ $3.84 Million
0.043x -53.06%
2018-03-31 Rs7.67 Billion
≈ $82.99 Million
Rs699.36 Million
≈ $7.56 Million
0.091x -44.15%
2017-03-31 Rs6.67 Billion
≈ $72.13 Million
Rs1.09 Billion
≈ $11.77 Million
0.163x +39.04%
2016-03-31 Rs5.95 Billion
≈ $64.40 Million
Rs698.78 Million
≈ $7.56 Million
0.117x -54.10%
2015-03-31 Rs5.59 Billion
≈ $60.49 Million
Rs1.43 Billion
≈ $15.46 Million
0.256x -44.27%
2014-03-31 Rs2.64 Billion
≈ $28.60 Million
Rs1.21 Billion
≈ $13.12 Million
0.459x +130.90%
2013-03-31 Rs1.54 Billion
≈ $16.70 Million
Rs306.86 Million
≈ $3.32 Million
0.199x -24.39%
2012-03-31 Rs1.28 Billion
≈ $13.79 Million
Rs335.07 Million
≈ $3.62 Million
0.263x +503.70%
2011-03-31 Rs1.27 Billion
≈ $13.71 Million
Rs55.16 Million
≈ $596.55K
0.044x -60.24%
2010-03-31 Rs1.18 Billion
≈ $12.77 Million
Rs129.25 Million
≈ $1.40 Million
0.109x -63.45%
2009-03-31 Rs1.14 Billion
≈ $12.38 Million
Rs342.73 Million
≈ $3.71 Million
0.299x +709.03%
2008-03-31 Rs1.06 Billion
≈ $11.51 Million
Rs39.38 Million
≈ $425.92K
0.037x -76.86%
2007-03-31 Rs1.02 Billion
≈ $10.98 Million
Rs162.41 Million
≈ $1.76 Million
0.160x +161.76%
2006-03-31 Rs902.12 Million
≈ $9.76 Million
Rs55.13 Million
≈ $596.25K
0.061x +135.07%
2005-03-31 Rs811.85 Million
≈ $8.78 Million
Rs21.11 Million
≈ $228.26K
0.026x --

About Suven Life Sciences Limited

NSE:SUVEN India Drug Manufacturers - Specialty & Generic
Market Cap
$876.15 Million
Rs81.01 Billion INR
Market Cap Rank
#9377 Global
#474 in India
Share Price
Rs307.20
Change (1 day)
+0.03%
52-Week Range
Rs126.65 - Rs359.55
All Time High
Rs359.55
About

Suven Life Sciences Limited, a clinical-stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel therapeutics for the treatment of neurodegenerative disorders in India, the United States, Europe, and internationally. The company engages in drug discovery and development of new chemical entities in central nervous system diseases. Its product candida… Read more